Sector Gamma AS
- SEC CIK
- 0001475373
- 最新申報
- 2026/8/12
2025 年第 1 季持倉
持倉截至 2025/3/31，2025/5/13 申報。只含多頭部位，變化是跟 2024 年第 4 季比股數。
- 持股檔數
- 33
- 較 2024 年第 4 季 +3
- 總值
- $3.12 億
- 較 2024 年第 4 季 +$2,132 萬 (+7.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 435,000 | $2,653 萬 | 8.5% | +68,834+18.8% | 加碼 | 歷史 |
| PFEPfizer Inc | Stock | 925,000 | $2,344 萬 | 7.5% | −230,000−19.9% | 減碼 | 歷史 |
| BDXBecton Dickinson & Co | Stock | 82,000 | $1,878 萬 | 6.0% | +6,000+7.9% | 加碼 | 歷史 |
| MDTMedtronic plc | Stock | 205,000 | $1,842 萬 | 5.9% | −115,000−35.9% | 減碼 | 歷史 |
| AMGNAmgen Inc | Stock | 59,000 | $1,838 萬 | 5.9% | +13,000+28.3% | 加碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 98,000 | $1,625 萬 | 5.2% | +20,000+25.6% | 加碼 | 歷史 |
| GILDGilead Sciences, Inc. | Stock | 140,000 | $1,569 萬 | 5.0% | −57,500−29.1% | 減碼 | 歷史 |
| CVSCVS Health Corp | Stock | 202,000 | $1,369 萬 | 4.4% | −15,000−6.9% | 減碼 | 歷史 |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 113,631 | $1,286 萬 | 4.1% | −24,083−17.5% | 減碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 28,779 | $1,252 萬 | 4.0% | +11,500+66.6% | 加碼 | 歷史 |
| CAHCardinal Health Inc | Stock | 88,000 | $1,212 萬 | 3.9% | 00.0% | 不變 | 歷史 |
| CNCCentene Corp | Stock | 177,000 | $1,075 萬 | 3.4% | +7,000+4.1% | 加碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 137,348 | $970.9 萬 | 3.1% | −80,000−36.8% | 減碼 | 歷史 |
| INCYIncyte Corp | COM | 159,000 | $962.7 萬 | 3.1% | −38,400−19.5% | 減碼 | 歷史 |
| EWEdwards Lifesciences Corp | Stock | 123,000 | $891.5 萬 | 2.9% | +24,000+24.2% | 加碼 | 歷史 |
| BRKRBruker Corp | COM | 211,970 | $884.8 萬 | 2.8% | +53,000+33.3% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 285,842 | $862.4 萬 | 2.8% | +50,000+21.2% | 加碼 | 歷史 |
| BAXBaxter International Inc | Stock | 247,650 | $847.7 萬 | 2.7% | +89,000+56.1% | 加碼 | 歷史 |
| QGENQiagen N.V. | COMMON STOCK | 187,000 | $750.8 萬 | 2.4% | +187,000 | 新進 | 歷史 |
| HUMHumana Inc | Stock | 25,000 | $661.5 萬 | 2.1% | +11,000+78.6% | 加碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 43,000 | $578.4 萬 | 1.9% | +21,000+95.5% | 加碼 | 歷史 |
| ELANElanco Animal Health Inc | COM | 477,073 | $500.9 萬 | 1.6% | +200,166+72.3% | 加碼 | 歷史 |
| GEHCGE HealthCare Technologies Inc. | Stock | 62,000 | $500.4 萬 | 1.6% | +12,000+24.0% | 加碼 | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 92,250 | $470.1 萬 | 1.5% | +27,000+41.4% | 加碼 | 歷史 |
| TNDMTandem Diabetes Care Inc | COM NEW | 180,523 | $345.9 萬 | 1.1% | +180,523 | 新進 | 歷史 |
| BIOBio-Rad Laboratories, Inc. | CL A | 13,829 | $336.8 萬 | 1.1% | −3,000−17.8% | 減碼 | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 30,000 | $273.2 萬 | 0.9% | −10,000−25.0% | 減碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 17,000 | $265.0 萬 | 0.8% | +17,000 | 新進 | 歷史 |
| BIIBBiogen Inc. | COM | 18,639 | $255.1 萬 | 0.8% | −10,361−35.7% | 減碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 25,000 | $244.0 萬 | 0.8% | −712−2.8% | 減碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 35,000 | $229.6 萬 | 0.7% | +35,000 | 新進 | 歷史 |
| SOLVSolventum Corp | Stock | 30,000 | $228.1 萬 | 0.7% | +30,000 | 新進 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 55,000 | $216.9 萬 | 0.7% | +55,000 | 新進 | 歷史 |
2024 年第 4 季之後清倉（3 檔）
2024 年第 4 季季末還持有、這份申報已經沒有的部位。